Cullen McCarthy, MD
Vascular Surgery · Mobile, ALNPI 1104262112
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,643 of the $7,690 with a category attached, or 60.4%. 19 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 30.5% of the total.
Across 67 payments — averaging $114.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Endologix LLC$2K
- Silk Road Medical, Inc.$2K
- Medtronic$447
- Cook Medical LLC$298
- Penumbra, Inc.$277
- plus $840 from 13 others
What the payments were for
- Travel & lodging$2,25029%
- Food & beverage$4,64360%
- Education$79610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 22 | $2,349 |
| Endologix LLC | 5 | $1,799 |
| Silk Road Medical, Inc. | 7 | $1,680 |
| Medtronic | 5 | $447 |
| Cook Medical LLC | 5 | $298 |
| Penumbra, Inc. | 3 | $277 |
| Boston Scientific | 3 | $214 |
| Kerecis Limited | 2 | $134 |
| Baxter Healthcare | 3 | $125 |
| Abbott | 3 | $88 |
| KCI USA, Inc. | 1 | $84 |
| Davol Inc. | 1 | $45 |
| BD | 1 | $41 |
| Veryan Medical Incorporated | 1 | $28 |
| Pfizer | 1 | $21 |
| Osiris Therapeutics Inc. | 1 | $20 |
| Lemaitre Vascular, Inc. | 1 | $14 |
| GE HealthCare | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$1,443
- ENROUTE Transcarotid Stent$1,443
- Alto Abdominal Stent Graft System$969
- ENDOCROSS Device$745
- Torus Stent Graft System$745
- TAG Thoracic Endoprosthesis$588
- Kerecis Omega3 SurgiClose$372
- EXCLUDER AAA Endoprosthesis$300
- Vascular Graft$259
- GORE TAG Conformable Thoracic Endoprosthesis$252
- Endurant$196
- VIABAHN VBX Balloon Expandable Endoprosthesis$166
- Zenith Spiral-Z$148
- Penumbra System$128
- Indigo System$125
- Kerecis Omega3 GraftGuide$124
- Kerecis Omega3 Marigen$124
- ROTAPRO$110
How this compares
$7,690 in reported general payments places this provider in the 60th percentile of 61 vascular surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 91 | $62,817 |
| XareltoRivaroxaban | 32 | $24,897 |
| ClopidogrelClopidogrel Bisulfate | 198 | $1,847 |
| Atorvastatin Calcium | 51 | $536 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 84 | $522 |
| Gabapentin | 23 | $334 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $112 |
| Tramadol Hcl | 17 | $87 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $21 | $62,81791 claims |
| Johnson & JohnsonXarelto | $12 | $24,89732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 61 vascular surgery providers in Alabama.
Other vascular surgery in Mobile
- Mina JacobMobile$19K
- Benjamin MakamsonMobile$18K
- Lee FergusonMobile$13K
- Glenn EssesMobile$7K
- Michael DoMobile$7K
- Lewis LyonsMobile$6K
- William HardyMobile$3K
- Melanie RoseMobile$3K
- Ralph PfeifferMobile$2K
- Albert PacificoBirmingham$5.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.